ArticlePharmaceuticals (Basel, Switzerland)2023

First Evidence of Activity of Enfortumab Vedotin on Brain Metastases in Urothelial Cancer Patients.

Christof Vulsteke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.